Outpatient intra-arterial yttrium-90 (Y-90) radioembolization provides an anti-tumoral effect in liver cancer patients where chemotherapy failed, according to a multi-institutional study presented at the Society of Interventional Radiology's 36th annual scientific meeting in Chicago. The study examined the impact of treating liver tumors with higher doses of Y-90 than previously tried.